title: Nifedipine-induced gingival hyperplasia.
abstract: Gingial hyperplasia is a complication which may be seen in a significant number of patients taking nifedipine (Procardia, Pfizer) a commonly used medication for cardiac vessel dilitation. This is a report of gingival changes in a 43-year-old hypertensive male who began using the calcium channel blocking agent during his active dental treatment. Gingival hyperplasia developed which was severe enough to alter the course of his dental treatment and prompt his changing to other medications to control his blood pressure. The recognition that the drug was responsible for the hyperplasia led to prompt and effective methods to resolve this problem.
authors.forename: E J
authors.initials: EJ
authors.lastname: Burkes
authors.forename: J R
authors.initials: JR
authors.lastname: Jacoway
authors.forename: D T
authors.initials: DT
authors.lastname: Stevens
authors.forename: M E
authors.initials: ME
authors.lastname: Braddock
mesh_terms: D005885:Gingival Hyperplasia / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000009:adverse effects*
chemical_list: D009543:Nifedipine